Concepedia

Publication | Open Access

A phase I study of subcutaneous recombinant interleukin-2 and interferon alfa-2a

DOIFull Paper Access

20

Citations

22

References

1993

Year

Mark J. Ratain, Edwin R. Priest, Linda Janisch, Nicholas J. Vogelzang
Cancer

Abstract

Subcutaneous interferon alfa-2a and IL-2 can be self-administered safely on an outpatient basis. At tolerable doses, responses can be achieved in metastatic RCC.

References

YearCitations

Page 1